(Q38167639)

30 August 2017

title

Inflammatory mediators as biomarkers in brain disorders (English)

1 reference

30 August 2017

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292800%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Pasquale Picone

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292800%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Marta Di Carlo

series ordinal

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292800%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

3

Luca Caruana

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292800%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

4

Sonya Vasto

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292800%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

5

Annalisa Barera

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292800%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

6

Calogero Caruso

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292800%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

publication date

1 June 2014

1 reference

30 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292800%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292800%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292800%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

639-648

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292800%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10753-013-9780-2

9 June 2020

exact match

0 references

cites work

Mechanisms underlying inflammation in neurodegeneration

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Inflammation in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Parkinson's disease in the nuclear age of neuroinflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

A critical role of astrocyte-mediated nuclear factor-κB-dependent inflammation in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Epidemiology of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Alzheimer disease in the United States (2010-2050) estimated using the 2010 census

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

TLR4 polymorphisms and ageing: implications for the pathophysiology of age-related diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Alpha 1-antichymotrypsin and IL-1 beta are not increased in CSF or serum in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Cerebrospinal fluid S100B correlates with brain atrophy in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

High interleukin-6 plasma levels are associated with functional impairment in older patients with vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer's disease and non-demented elderly subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Neurochemical dementia diagnostics: State of the art and research perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Blood-based protein biomarkers for diagnosis of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Multidimensional plasma protein separation technique for identification of potential Alzheimer's disease plasma biomarkers: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

View point: etiology in Parkinson's disease. Dual hit or spreading intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Role of mendelian genes in "sporadic" Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

ParkDB: a Parkinson's disease gene expression database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Parkinson disease: insights in clinical, genetic and pathological features of monogenic disease subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Can Parkinson's disease pathology be propagated from one neuron to another?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Parkinson's Disease: Genetics and Pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Missing pieces in the Parkinson's disease puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Neuroinflammation in Parkinson's disease: a target for neuroprotection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Nitrated alpha-synuclein and microglial neuroregulatory activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Peripheral inflammatory biomarkers and risk of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Association of fibrinogen with Parkinson disease in elderly Japanese-American men: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Recent advances in CSF biomarkers for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

CSF xanthine, homovanillic acid, and their ratio as biomarkers of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Influence of temperature changes on multiple sclerosis: critical review of mechanisms and research potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: A population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Expression of amyotrophic lateral sclerosis-linked SOD1 mutant increases the neurotoxic potential of microglia via TLR2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Unbiased reconstruction of a mammalian transcriptional network mediating pathogen responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Involvement of the pro-oncoprotein TLS (translocated in liposarcoma) in nuclear factor-kappa B p65-mediated transcription as a coactivator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Glial reactions in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (sALS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Immune system alterations in sporadic amyotrophic lateral sclerosis patients suggest an ongoing neuroinflammatory process.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Biomarkers in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Amyotrophic lateral sclerosis multiprotein biomarkers in peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Plasma neurofilament heavy chain levels correlate to markers of late stage disease progression and treatment response in SOD1(G93A) mice that model ALS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Neuroinflammation in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Huntingtin-protein interactions and the pathogenesis of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Trinucleotide Repeat Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Huntington's disease: from pathology and genetics to potential therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Activation of the IkappaB kinase complex and nuclear factor-kappaB contributes to mutant huntingtin neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Role of microglial IKKbeta in kainic acid-induced hippocampal neuronal cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Cerebrospinal fluid correlates of depression in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Cerebrospinal fluid levels of quinolinic acid in Huntington's disease and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Cerebrospinal fluid F2-isoprostanes are elevated in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

N(epsilon)-(gamma-L-glutamyl)-L-lysine (GGEL) is increased in cerebrospinal fluid of patients with Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Identification and validation of novel CSF biomarkers for early stages of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9780-2

Atorvastatin attenuates the production of IL-1β, IL-6, and TNF-α in the hippocampus of an amyloid β1-42-induced rat model of Alzheimer's disease

21 January 2018

1 reference

12 December 2020

Identification of blood microRNAs associated to Parkinsonĭs disease

1 reference

12 December 2020

Potential inflammatory biomarkers in Alzheimer's disease

1 reference

12 December 2020

Pathophysiology of Huntington's disease: from huntingtin functions to potential treatments

1 reference

12 December 2020

Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease.

1 reference

12 December 2020

World Federation of Neurology Research Group on Neuromuscular Diseases Subcommittee on Motor Neuron Disease. Airlie House guidelines. Therapeutic trials in amyotrophic lateral sclerosis. Airlie House "Therapeutic Trials in ALS" Workshop Contributors

1 reference

12 December 2020

Current therapeutic strategy in Alzheimer's disease

1 reference

12 December 2020

Low-grade systemic inflammation in patients with amyotrophic lateral sclerosis

1 reference

12 December 2020

Inflammation in Alzheimer disease: driving force, bystander or beneficial response?

1 reference

12 December 2020

Alpha 1-antichymotrypsin level in cerebrospinal fluid is closely associated with late onset Alzheimer's disease.

1 reference

12 December 2020

Interleukin-8 receptor B immunoreactivity in brain and neuritic plaques of Alzheimer's disease

1 reference

12 December 2020

Clinical characteristics of SOD1 gene mutations in UK families with ALS

1 reference

12 December 2020

Matrix metalloproteinase-9 is elevated in serum of patients with amyotrophic lateral sclerosis

1 reference

12 December 2020